Stoke Therapeutics, Inc. · NASDAQ:STOK
Morgan Stanley reported a 6.50% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 3, 2025
Morgan Stanley reported a 6.50% stake in Stoke Therapeutics, Inc., 3,426,739 shares, as a passive investor on Dec 31, 2024. Filed Feb 3, 2025 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 3,426,739
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 6.50% | 3,426,739 |
| Morgan Stanley Capital Services LLC | 5.40% | 2,879,280 |